"Effect of Agalsidase Alfa Replacement Therapy on Fabry Disease-Related Hypertrophic Cardiomyopathy: A 12-to 36-Month, Retrospective, Blinded Echocardiographic Pooled Analysis" . . "The study summarizes blinded echocardiuographic analysis of long-term follow-up in patients with Fabry disease treated with alalsidase alfa. In a subset of patients, the study confirmed beneficial results on left ventricular hypertrophy."@en . "4"^^ . "Schiffmann, R." . . . "Effect of Agalsidase Alfa Replacement Therapy on Fabry Disease-Related Hypertrophic Cardiomyopathy: A 12-to 36-Month, Retrospective, Blinded Echocardiographic Pooled Analysis"@en . . . "RIV/00064165:_____/09:4230" . "Kampmann, C." . . . "0149-2918" . "RIV/00064165:_____/09:4230!RIV10-MZ0-00064165" . . "11"^^ . . . . . "31" . . "V" . "Clinical Therapeutics" . . . . . . . "9" . . "Linhart, Ale\u0161" . "Effect of Agalsidase Alfa Replacement Therapy on Fabry Disease-Related Hypertrophic Cardiomyopathy: A 12-to 36-Month, Retrospective, Blinded Echocardiographic Pooled Analysis"@en . "[0F323FA9EFB4]" . . . . "Effect of Agalsidase Alfa Replacement Therapy on Fabry Disease-Related Hypertrophic Cardiomyopathy: A 12-to 36-Month, Retrospective, Blinded Echocardiographic Pooled Analysis" . "000271043100007" . "Devereux, RB" . . . "Fabry disease; agalsidase alfa; cardiomyopathy; heart disease; left-ventricular hypertrophy; m-mode echocardiography; clinical-manifestations; cardiac manifestations; natural-history; outcome survey; beta therapy; impact; trial; galactosidase"@en . "311987" . "US - Spojen\u00E9 st\u00E1ty americk\u00E9" . "The study summarizes blinded echocardiuographic analysis of long-term follow-up in patients with Fabry disease treated with alalsidase alfa. In a subset of patients, the study confirmed beneficial results on left ventricular hypertrophy." . "1"^^ .